ABCG2 and non-small cell lung carcinoma: It has been reported that chemotherapeutic efficacy in patients of non-small cell lung cancer is positively correlated with the level of ABCG2 expression and independent on ABCB1, ABCC1 and ABCC3, suggesting that specific suppression of ABCG2 may help to circumvent MDR in these patients12.